Stockreport

Voyager Therapeutics Reports First Quarter 2019 Financial Results and Corporate Highlights

Voyager Therapeutics, Inc.  (VYGR) 
Last voyager therapeutics, inc. earnings: 3/3 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.voyagertherapeutics.com
PDF FDA grants orphan-drug designation for VY-HTT01 for Huntington’s disease Begins strategic collaboration with Neurocrine Biosciences on gene therapy programs for Parkins [Read more]